| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |